HomeBTLS • EBR
add
Biotalys NV
Previous close
€2.68
Day range
€2.69 - €2.70
Year range
€1.62 - €6.40
Market cap
87.18M EUR
Avg Volume
8.99K
P/E ratio
-
Dividend yield
-
Primary exchange
EBR
Market news
Financials
Income Statement
Revenue
Net income
(EUR) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 5.02M | -21.49% |
Net income | -4.92M | 23.31% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -4.61M | 24.79% |
Effective tax rate | -0.16% | — |
Balance Sheet
Total assets
Total liabilities
(EUR) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 21.57M | -36.74% |
Total assets | 36.58M | -26.12% |
Total liabilities | 11.01M | -3.42% |
Total equity | 25.57M | — |
Shares outstanding | 32.09M | — |
Price to book | 3.35 | — |
Return on assets | -34.29% | — |
Return on capital | -39.65% | — |
Cash Flow
Net change in cash
(EUR) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -4.92M | 23.31% |
Cash from operations | -4.88M | 7.26% |
Cash from investing | 106.50K | 159.83% |
Cash from financing | -379.50K | -30.64% |
Net change in cash | -5.16M | 10.01% |
Free cash flow | -2.65M | 21.72% |
About
Founded
2013
Website
Employees
77